Journal of Urology

Article	Citations
Urological Oncology: Bladder, Penis and Urethral Cancer, and Basic Principles of Oncology	331
Urological Oncology: Prostate Cancer	229
Editorial Comment	226
MP12-03 IL-7 AND CCL19 PRODUCING CAR-T CELLS PREVENT ANTIGEN-LOSS TUMOR RELAPSE AND ENHANCE ANTITUMOR EFFICACY AGAINST SOLID CANCER	226
MP54-13 THE UPDATE FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT FOR LOW-GRADE BLADDER TUMORS: LONG-TERM ONCOLOGICAL OUTCOMES OF PATIENTS UNDER ACTIVE SURVEILLANCE	192
PD40-10 FORMAL VALIDATION AT FINAL PATHOLOGY AFTER RADICAL NEHRECTOMY OF NEPHROMETRY SCORES: DISCORDANCE RATES AND OVERTREATMENT RISK	178
PD23-04 EXPLORING ACTINIDIN AS A NOVEL COLLAGENASE TO TREAT HUMAN PEYRONIE’S DISEASE CELLS	168
MP46-04 10-YEAR EXPERIENCE WITH MIDLINE EXTRAPERITONEAL RETROPERITONEAL LYMPH NODE DISSECTION	162
MP21-16 DEMOGRAPHICS AND INCIDENTAL DIAGNOSES OF MEN WITH PRIAPISM	136
PD35-06 HEALTH-RELATED QUALITY OF LIFE IN LOW-INCOME MEN AFTER SURGICAL CASTRATION FOR METASTATIC PROSTATE CANCER	132
MP21-11 SEVERITY OF PENILE CURVATURE IN PEYRONIE’S DISEASE DOES NOT CORRELATE WITH SHIM OR PDQ SCORES	111
MP40-04 PREDICTIVE RISK FACTORS FOR EARLY RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA	111
This Month in Adult Urology	106
LBA02-02 DEVELOPMENT OF A MULTIPHASIC BLADDER PATCH COMPOSED OF COLLAGEN, AMNIOTIC MEMBRANE, AND PATIENT-DERIVED EPITHELIAL CELLS	102
PD39-05 PROSTATE MEASUREMENT ON COMPUTED TOMOGRAPHY: VARIANCE DECREASES AS PROSTATE VOLUME INCREASES	95
MP11-04 PELVIC ORGAN PROLAPSE IS NOT UNCOMMON AMONG WOMEN WITH SPINA BIFIDA	92
V07-04 SINGLE PORT TRANSVESICAL PARTIAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER	90
MP34-01 IS TESTIS SPARING SURGERY A SAFE APPROACH IN PATIENTS WITH SMALL TESTICULAR LESIONS REFERRING TO A FERTILITY CENTER? A RETROSPECTIVE ANALYSIS REPORTING LONG-TERM ONCOLOGICAL OUTCOMES AND FACTO	87
Editorial Comment	82
PD15-05 PROGNOSTIC VALUE OF EARLY DYNAMIC CHANGE OF NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN PATIENTS WITH UPPER-TRACT UROTHELIAL CARCINOMA (UTUC) TREATED WITH NEPHROURETERECTOMY	78
PD18-08 PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO FOR SMALL RENAL CELL CARCINOMAS AFTER IMAGE-GUIDED CRYOABLATION (CRYO) OR RADIO-FREQUENCY ABLATION (RFA)	73
PD23-09 AUXETIC EXPANSION OF THE TUNICA ALBUGINEA FOR PENILE LENGTH AND GIRTH RESTORATION WITHOUT A GRAFT: A CASE SERIES.	63
MP24-01 RACE BASED EQUATIONS FOR ESTIMATING KIDNEY FUNCTION MAY CONTRIBUTE TO RACIAL DISPARITIES IN PARTIAL NEPHRECTOMY UTILIZATION AMONG BLACK PATIENTS WITH KIDNEY TUMORS	61
MP05-16 NEW PERSPECTIVES ON AN OLD GROUPING: THE GENOMIC AND PHENOTYPIC DIFFERENCES OF OXALOBACTER FORMIGENES	61
PD19-03 ASSESSMENT OF FACTORS INVOLVED IN LASER FIBER DEGRADATION WITH THULIUM FIBER LASER	60

MP45-07 ONCOLOGIC OUTCOMES OF TOTAL LENGTH GLEASON PATTERN 4 ON BIOPSY IN MEN WITH GRADE GROUP 2 PROSTATE CANCER	59
MP17-03 COMPLICATION RATES AMONG DIFFERENT TREATMENT MODALITIES FOR THE SURGICAL MANAGEMENT OF VESICOURETERAL REFLUX IN CHILDREN	57
MP58-16 DOES VETERAN STATUS MITIGATE RACIAL DISPARITIES IN PROSTATE CANCER SCREENING? ANALYSIS OF PROSTATE-SPECIFIC ANTIGEN SCREENING PATTERNS IN THE 2018 BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM DA	56
MP56-17 RADICAL CYSTECTOMY VIDEO CONSENSUS: A SIMPLE AND EFFECTIVE WAY TO IMPROVE AWARENESS OF PATIENTS UNDERGOING RADICAL CYSTECTOMY	56
MP14-17 MORTALITY ASSOCIATED WITH SEPSIS POST-URETEROSCOPY AMONG A US-BASED COMMERCIAL POPULATION	55
PD55-02 PREDICTION OF CHEMICAL COMPOSITION OF URINARY STONE THROUGH DEEP LEARNING	55
MP26-09 ACCURACY OF DIAGNOSTIC CODES IN A CLINICAL RESEARCH NETWORK TO IDENTIFY PRIMARY HYPEROXALURIA PATIENTS	54
PD58-08 SURVIVAL OUTCOMES IN SOLITARY KIDNEY PATIENTS DIAGNOSED WITH UPPER TRACT UROTHELIAL CARCINOMA	53
PD08-02 URINARY DIVERSION FOR INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: PREVALENCE AND PERIOPERATIVE COMPLICATION RATE	53
MP33-09 RADIOGENOMIC CORRELATES OF CLINICALLY RELEVANT CLEAR CELL RENAL CELL CANCER BIOMARKERS	53
MP47-08 SURGICAL DELAY AFTER BIOPSY AND RISK OF UPSTAGING FOR CLINICAL T1A RENAL CELL CARCINOMA	52
MP06-18 A GENOMIC URINE ASSAY TO DETECT URINARY TRACT RECURRENCES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADIOTHERAPY	52
MP56-19 TRIMODAL THERAPY VERSUS RADICAL CYSTECTOMY FOR T2 BLADDER CANCER: REAL-WORLD EVIDENCE FROM ONTARIO	51
MP24-13 IMPACT OF PRIMARY TUMOR SIZE ON CANCER-SPECIFIC AND ALL-CAUSE MORTALITY IN PATIENTS UNDERGOING CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: ANALYSIS FROM THE INTERNATIONAL MA	51
MP11-12 PRENATAL DIAGNOSIS OF BLADDER AND CLOACAL EXSTROPHY OVER 20 YEARS	49
PD41-12 FROM BIOPSY TO DIAGNOSIS IN 30 MIN: REMOTE INSTANT PROSTATE PATHOLOGY BASED ON ARTIFICIAL INTELLIGENCE ENHANCED ULTRASOUND (AI-US)	47
PD53-06 CHANGES IN MOUSE STOOL MICROBIOME WITH EXPOSURE TO BLADDER CARCINOGEN N-BUTYL-N-(4-HYDROXYBUYTL) NITROSAMINE (BBN): LONGITUDINAL ANALYSIS	46
V11-06 DYNAMIC SENTINEL LYMPH NODE BIOPSY FOR PENILE CANCER: ACCURACY IS IN THE TECHNIQUE	44
PD13-01 THE CONTINUING IMPACT OF THE COVID-19 PANDEMIC ON PROSTATE CANCER MANAGEMENT: A POPULATION BASED ANALYSIS	44
PD51-01 CONTEMPORARY SURGICAL OUTCOMES OF RETROPERITONEAL LYMPH NODE DISSECTION FROM THE SEMS TRIAL	41
PD45-02 UROLIFT VERSUS REZUM FOR BENIGN PROSTATIC HYPERPLASIA: A REAL-WORLD SINGLE-INSTITUTION ANALYSIS	40
MP29-04 EFFECT OF SURGEON VOLUME AND FACILITY VOLUME ON OUTCOMES OF BENIGN PROSTATIC HYPERPLASIA SURGERY	40
Editorial Comment	38
Imaging	37
The Journal of Urology® Home Study Course 2022 Volume 207/208	37
MP46-01 COLLABORATIVE RESILIENCE PROGRAM TO ENHANCE QUALITY OF LIFE FOR POST-PENECTOMY PATIENTS: DYADIC COPING PERSPECTIVE	36
Urological Oncology: Testis Cancer and Advances in Oncologic Therapy	34
V10-11 PARTIAL NEPHRECTOMY IN COMPLEX KIDNEY MASSES - TWO APPROACHES WITH THE DAVINCI SINGLE PORT ROBOT	33
LBA02-10 ASSESSING THE RISKS OF A POSITIVE URINE CULTURE IN UNCOMPLICATED RENAL COLIC PATIENTS	33
MP04-08 TRANEXAMIC ACID TO IMPROVE SAME-DAY DISCHARGE RATES AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE: A RANDOMIZED, CONTROLLED PROSPECTIVE TRIAL	32
MP40-02 CAN THE PRESENTATION OF UPPER TRACT UROTHELIAL CANCER GUIDE US ON HOW TO IMAGE NON-VISIBLE HAEMATURIA?: A REVIEW OF 10 YEARS	32
Editorial Comment	31
“Bottoms Up!”: A Toast to Reexamining the Debate of Top-Down vs Bottom-Up Approach for the Evaluation of Febrile Urinary Tract Infection	31
Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Implications for Clinical Trial Design. Reply.	31
MP28-09 IMPACT OF SPIRITUALITY ON QUALITY OF LIFE IN LOW-INCOME MEN WITH PROSTATE CANCER	30
MP59-17 DEVELOPMENT AND INTERNAL VALIDATION OF A PREDICTIVE MODEL FOR RECURRENCE-FREE SURVIVAL IN PTA LOW-GRADE BLADDER CANCER	30
Geriatrics	30
MP46-05 CHARACTERIZING ONLINE TESTICULAR CANCER DISCUSSIONS WITH QUANTITATIVE THEMATIC ANALYSIS	29
MP06-15 VIRTUAL REALITY IMMERSION FOR REDUCING ANXIETY AND PAIN DURING TRANSPERINEAL PROSTATE BIOPSY: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL	29
MP09-02 IS IT CLINICALLY AND ONCOLOGICALLY SAFE TO OMIT PROSTATE BIOPSY IN LOW RISK STRATIFIED PATIENTS?	29
PD51-11 CONCOMITANT VS STAGED LYMPHADENECTOMY IN CLINICALLY NODE-POSITIVE PENILE SQUAMOUS CELL CARCINOMA: RECURRENCE PATTERNS AND SURVIVAL OUTCOMES	29
PD18-04 HAZARD OF DEATH IN VON HIPPEL-LINDAU DISEASE PATIENTS DEPENDS ON GENOTYPE AND ONSET AGE AS WELL AS FIRST AFFECTED LESION	29
MP40-03 CIRCULATING CHROMOSOME CONFORMATION SIGNATURES ENHANCE THE ACCURACY OF PSA FOR DETECTING PROSTATE CANCER - RESULTS FROM PERFORMANCE OF THE EPISWITCH TM PCA T	28
MP17-14 IDENTIFYING CRIBRIFORM PATTERN IN MPMRI SCANS FROM 3D RECONSTRUCTED RALP SPECIMENS USING DEEP LEARNING	28
MP27-09 OXYMATRINE IMPROVES ERECTILE FUNCTION THROUGH SUPPRESSION OF INFLAMMATION AND FIBROSIS IN DIABETIC RATS	28
V02-10 LIMITED RESOURCES IMPROVISED BASKETS FOR PCNL	27
PD33-08 BACTERIAL BIOFILMS FROM INDWELLING SACRAL NEUROMODULATION DEVICES ARE RECONSTITUTABLE IN VITRO AND EXHIBIT DIFFERENTIAL FORMATION BY MATERIAL TYPE	27
MP22-04 MAINTENANCE OF SKELETAL MUSCLES WHEN RECEIVING NEOADJUVANT CHEMOTHERAPY IMPROVES THE PROGNOSIS FOR PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER	27
MP67-12 FIRST LOOK: LASER SPECKLE IMAGING IS A NOVEL METHOD TO IDENTIFY AND PRESERVE NEUROVASCULAR BUNDLE DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY	26
PD23-04 URINARY PROTEINS IN THE DIAGNOSIS OF MIXED INTRINSIC SPHINCTER DEFICIENCY AND DETRUSOR OVERACTIVITY IN FEMALE PATIENTS WITH STRESS URINARY INCONTINENCE?	26

PD32-07 RACE MODIFIED ESTIMATED GLOMERULAR FILTRATION RATE UNDERESTIMATES CHRONIC KIDNEY DISEASE PREVALENCE IN AFRICAN-AMERICAN PATIENTS UNDERGOING PARTIAL AND RADICAL NEPHRECTOMY: IMPLICATIONS FOR SU	26
PD27-02  99m TC-PSMA RADIOGUIDED SURGERY USING A DROP-IN GAMMA PROBE IN RADICAL PROSTATECTOMY: INITIAL RESULTS	25
PD08-12 PREDICTORS OF PROGRESSION AND DELAYED INTERVENTION IN SMALL RENAL MASS PATIENTS UNDERGOING ACTIVE SURVEILLANCE WITHOUT HEALTH-RELATED SELECTION BIAS	25
PD12-11 URETHRAL COMPLICATIONS AFTER METOIDIOPLASTY WITH URETHRAL RECONSTRUCTION	25
MP11-08 EXPLORING THE EFFECT OF METASTASIS DIRECTED THERAPY ON PROGRESSION PATTERNS OF PATIENTS WITH POSITIVE 68Ga-PSMA PET/CT AND BIOCHEMICAL RECURRENCE FROM PROSTATE CANCER	25
MP64-20 UNDERSTANDING CLINICAL OUTCOMES IN PATIENTS RENDERED NO EVIDENCE OF DISEASE IN METASTATIC RENAL CELL CARCINOMA	25
V07-07 WIRE-GUIDED EXTRAVESICAL ROBOT-ASSISTED BLADDER DIVERTICULECTOMY AND Y-V PLASTY FOR RECURRENT BLADDER NECK STRICTURE	24
LBA01-08 EFFICACY OF TARGETED MAST CELL INHIBITION THERAPY IN CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME	24
V04-06 ROBOTIC ASSISTED TRANS-VESICOSCOPIC URETERIC REIMPLANTATION IN CHILDREN: SURGICAL ERGONOMICS RELATED TO MUSCULOSKELETAL SYMPTOMS	24
MP53-20 INITIAL UROLOGIC EVALUATION FOR ANORECTAL MALFORMATIONS: A PCPLC RETROSPECTIVE	24
MP28-03 CYTOREDUCTIVE NEPHRECTOMY FOLLOWING IMMUNE CHECKPOINT INHIBITORS IS SAFE AND FACILITATES TREATMENT FREE INTERVALS	24
PD04-08 BALIXAFORTIDE, A CXCR4 INHIBITOR, SYNERGIZES WITH DOCETAXEL TO DIMINISH TUMOR GROWTH IN A PROSTATE CANCER MODEL OF BONE METASTASIS	24
PD43-02 FUNCTIONAL OUTCOMES AFTER SELECTIVE CLAMPING IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY	23
MP66-14 WEBSITE TRANSPARENCY AND INFORMATION DISSEMINATION AMONG UROLOGY RESIDENCY PROGRAMS	23
MP38-19 FOCAL THERAPY CANDIDACY: AN EVALUATION OF INITIAL AND CONTINUED ELIGIBILITY FOR FOCAL THERAPY IN AN ACTIVE SURVEILLANCE COHORT	23
PD39-07 CAN WE STOP DOING SYSTEMATIC BIOPSIES IN MEN WITH PIRADS/LIKERT 5 LESIONS ON MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING? AN ANALYSIS FROM A MULTICENTRE PROSPECTIVE DATASET OF OVER 800 PATIENT	23
MP48-04 PERSPECTIVES OF SOCIETY OF WOMEN IN UROLOGY MEMBERS TOWARD DOBBS V. JACKSON WOMEN′S HEALTH ORGANIZATION	23
MP57-02 AN UPDATE ON PROFESSIONAL BURNOUT AND CONFLICT-WORK FROM THE AUA WORKFORCE WORKGROUP	22
PD17-03 REDOX IMBALANCE AND MAPK ACTIVATION MEDIATES PNEUMOPERITONEUM-INDUCED KIDNEY INJURY DURING MINIMALLY INVASIVE SURGERY	22
HF02-04 KEEPING IT REEL: PHOTOGRAPHY AND CINEMATOGRAPHY IN UROLOGY	22
MP70-07 HIGH-PERFORMING SCALABLE EXTRACTION OF ELEMENTS OF URINARY TRACT DILATION CLASSIFICATION USING NATURAL LANGUAGE PROCESSING ALGORITHMS FOR NEONATAL ULTRASOUND REPORTS	21
MP62-05 AUA RECOMMENDED ANTIBIOTIC PROPHYLAXIS FOR PRIMARY PENILE IMPLANTATION RESULTS IN A HIGHER, NOT LOWER, RISK FOR POST-OPERATIVE INFECTION: A MULTICENTER ANALYSIS	21
PD19-09 IMMUNOPROPHYLAXIS WITH AUTOVACCINE DECREASES HOSPITAL ADMISSIONS AND EMERGENCY ROOM VISITS IN PATIENTS WITH NEUROGENIC BLADDER	21
MP02-03 FASCIOCUTANEOUS FLAP CLOSURE OF THE PERINEUM AS AN ALTERNATIVE TO SCROTOPLASTY FOR EXTENSIVE GENITAL TISSUE LOSS	21
PD24-03 BEST TREATMENT FOR OLIGOMETASTATIC RENAL CANCER: A QUASI-INDIVIDUAL PATIENT DATA ANALYSIS	21
MP36-05 CLINIC SCORE - A NOVEL PREDICTION MODEL OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM OUTCOMES IN MEN WITH PEYRONIE’S DISEASE	21
MP07-15 LANGUAGE-RELATED DISPARITIES IN ACUTE POSTOPERATIVE PAIN MANAGEMENT FOLLOWING PELVIC FLOOR RECONSTRUCTIVE SURGERY	21
MP36-04 PREDICTORS OF PENILE PLICATION AFTER INTRALESIONAL COLLAGENASE CLOSTRIDIUM HISTOLYTICUM INJECTION IN MEN WITH PEYRONIE’S DISEASE	21
MP30-02 A NOVEL PREDICTION MODEL FOR POSSIBILITY OF SPERM RETRIEVAL IN MICRO TESE FOR NON-OBSTRUCTIVE AZOOSPERMIA PATIENTS USING AUTOMATED ARTIFICIAL INTELLIGENCE	21
MP12-03 IMPLICATIONS OF RACE FREE RENAL FUNCTION EQUATIONS ON BLACK PATIENTS WITH RENAL CELL CARCINOMA	21
PD14-12 SEXUAL FUNCTION IN WOMEN FOLLOWING TENSION-FREE VAGINAL TAPE-OBTURATOR PROCEDURE: A PROSPECTIVE STUDY	21
MP38-07 UPGRADING ON PER PROTOCOL VS FOR CAUSE SURVEILLANCE PROSTATE BIOPSIES: AN OPPORTUNITY TO DECREASING THE BURDEN OF ACTIVE SURVEILLANCE	20
PD47-12 DOES ANESTHESIA TYPE MATTER IN SHOCKWAVE LITHOTRIPSY?	20
PD31-09 DEVELOPMENT OF EXTREME GRADIENT BOOST (XGBOOST) MACHINE LEARNING MODEL USING AN INSTITUTIONAL PEDIATRIC KIDNEY TRANSPLANT DATABASE FOR PREDICTION OF DELAYED GRAFT FUNCTION	20
PD26-10 COMPARISON OF INTRAVESICAL THERAPY AND SURGERY AS TREATMENT OPTIONS FOR RECURRENT BLADDER CANCER (CISTO): UPDATE ON AN ONGOING MULTICENTER PRAGMATIC STUDY	20
MP41-18 CLINICAL MANIFESTATIONS OF BIRT-HOGG-DUBE SYNDROME IN A LARGE CLINICAL COHORT	20
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology	19
Reply by Authors	19
PD51-08 SREBP1 INDUCES RESISTANCE TO HIF-2α ANTAGONIST IN CLEAR CELL RENAL CELL CARCINOMA	19
Urologic Heterodoxy Leads to Discovery	19
Editorial Comment	19
Editorial Comment	19
MP15-18 MOLECULAR CHARACTERIZATION OF URETHRAL CANCER AND COMPARISON WITH BLADDER CANCER	19
MP57-13 IS BIPOLAR ENUCLEATION OF THE PROSTATE AN EFFECTIVE AND COST-EFFICIENT ALTERNATIVE TO ROBOTIC SIMPLE PROSTATECTOMY?	19
MP33-08 OPIOID PRESCRIBING PATTERNS AND POST-PROSTATECTOMY READMISSION	19
PD35-04 OPEN VS. ROBOTIC-ASSISTED RECONSTRUCTION IN VESICOURETHRAL ANASTOMOTIC STENOSIS	19
MP13-02 PATTERNS OF TELE-HEALTH USAGE AFTER THE COVID-19 PANDEMIC AMONG SURGICAL SPECIALTIES AND UROLOGY	18
PD58-09 GROWTH KINETICS OF ONCOCYTIC NEOPLASMS ON ACTIVE SURVEILLANCE AND IMPACT ON RENAL FUNCTION	18
MP76-14 PROPHYLACTIC DIPS AND IRRIGATION SOLUTIONS CAN CONSIDERABLY ALTER THE ANTIMICROBIAL EFFICACY OF INFLATABLE PENILE PROSTHESIS HYDROPHILIC SURFACE COATINGS	18
MP02-01 "DOCTOR 1 PUT ME IN TOUCH WITH A FORMER PATIENT... OF MY EXPERIENCE THROUGH IT, I THINK SHE HELPED ME THE MOST": PEER SUPPORT AS AN INVALUABLE RESOURCE IN THE SETTING OF BLADDER CANCER SURGERY	18
MP02-18 APPROPRIATENESS OF IMAGING FOR LOW-RISK PROSTATE CANCER – REAL WORLD DATA FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATION (PURC)	18
PD61-05 ONCOLOGICAL OUTCOMES OF NEOADJUVANT DEGARELIX WITH APALUTAMIDE (ARNEO TRIAL) VERSUS STANDARD OF CARE PRIOR TO RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A PROPENSITY SCORE MATCHED AN	18
MP62-13 LONG-TERM MEDICATION USE AFTER SURGICAL TREATMENT FOR BLADDER OUTLET OBSTRUCTION, HOW DOES HOLEP COMPARE TO OTHER SURGICAL MODALITIES?	18
MP24-16 URETEROSCOPY AT AMBULATORY SURGERY CENTERS CAN BE SAFE FOR CAREFULLY SELECTED HIGH-RISK PATIENTS	18
PD23-09 THE EFFECT OF ADRENALECTOMY ON OVERALL SURVIVAL IN METASTATIC ADRENOCORTICAL CARCINOMA	18
V02-06 A TECHNIQUE FOR COMBINED ROBOTIC SACROCOLPOPEXY AND VENTRAL MESH RECTOPEXY	18
MP01-10 THE LANDSCAPE OF RACIAL AND ETHNIC DISPARITY IN TESTICULAR CANCER STAGE PRESENTATION: A NATIONAL HOSPITAL-BASED STUDY	18
PD47-07 THE STUDY OF AUTOMATIC RECOGNITION OF STONE COMPONENTS USING DIGITAL IMAGES FROM INTRAOPERATIVE FLEXIBLE URETEROSCOPY	18
MP32-17 LONG-TERM FOLLOW-UP AND SUCCESS RATE OF VENTRAL INLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY VS DORSAL ONLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY FOR FEMALE URETHRAL STRICTURE DISEASE	17
MP08-20 SIGNIFICANT DROP OF EARLY AND TWO-YR MORTALITY FOR BLADDER CANCER PATIENTS RECEIVING RADICAL CYSTECTOMY IN THE LAST 20 YEARS: SINGLE CENTER ANALYSIS	17
MP31-07 PROSTATE EXTRACELLULAR VESICLES AND PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A PROSPECTIVE SINGLE-INSTITUTION PILOT STUDY	17
PD14-08 IDENTIFICATION OF A BLADDER CANCER SUBPOPULATION THAT MAY BENEFIT FROM DASATINIB	17
MP34-14 ASSOCIATION OF POPULATION-LEVEL SOCIAL DETERMINANTS OF HEALTH WITH UROLOGIC CANCER CLINICAL TRIALS AVAILABILITY	17
PD43-11 SOCIODEMOGRAPHIC FACTORS AND FRAILTY IMPACT ADVANCED THERAPY UTILIZATION AMONG MEDICARE BENEFICIARIES	16
PD58-01 PREVALENCE AND SPECTRUM OF GERMLINE MUTATIONS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA	16
PD52-01 A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL TO EVALUATE SAFETY AND EFFICACY OF PLATELET-RICH PLASMA INJECTIONS FOR PEYRONIE'S DISEASE: CLINICAL TRIAL UPDATE	16
MP03-13 ARTIFICIAL URETHRAL SPHINCTER PRESSURE REGULATING BALLOON AND CUFF VARIATIONS FOLLOWING DEVICE EXPLANTATION	16
MP63-07 THE BUTOX STUDY: THE ROLE OF THE GUT MICROBIOME AND BUTYRATE IN CALCIUM OXALATE KIDNEY STONE DISEASE	16
MP70-20 MORTALITY DISPARITIES AMONG ASIAN AMERICANS DIAGNOSED WITH UROLOGIC CANCER	16
PD27-01 DEVELOPMENT OF A MACHINE LEARNING (ML) MODEL TO AUTOMATICALLY AND PRECISELY IDENTIFY KIDNEY STONES FROM URETEROSCOPY VIDEO RECORDINGS	16
PD28-08 ASSOCIATION OF LOW TESTOSTERONE, FRAILTY, AND POSTOPERATIVE OUTCOMES AMONG MEN UNDERGOING UROLOGIC SURGERY	16
MP19-05 LEARNING CURVES OF FUSION-GUIDED BIOPSY AND ULTRASOUND PROSTATE SEGMENTATION: A SINGLE-CENTER STUDY INVOLVING 14 OPERATORS AND 1721 PATIENTS	16
MP69-05 DEVELOPING AN ANTIMICROBIAL IRRIGATION SOLUTION FOR ENDOUROLOGICAL PROCEDURES: EX VIVO EFFICACY AND IN VIVO SAFETY	16
V11-11 HUGO RAS SIMPLE PROSTATECTOMY SEC. MILLIN: STEP BY STEP SURGICAL PROCEDURE AND SET UP IN A THREE ARMS CONFIGURATION	16
MP21-06 USABILITY TESTING OF THE SET BRAVE GOALS APP, A CONTINENCE GOAL-SELECTION APP FOR CHILDREN WITH SPINA BIFIDA	16
PD61-12 SAME-DAY DISCHARGE FOLLOWING ROBOTIC PROSTATECTOMY: STANDARDIZATION AND SAFETY EVALUATION	16
MP36-11 GERIATRIC NUTRITIONAL RISK INDEX AS A SIGNIFICANT PROGNOSTIC FACTOR IN PATIENTS WITH CLEAR-CELL RENAL CELL CARCINOMA	16
MP44-05 PARENCHYMAL VOLUME ANALYSIS TO ASSESS LONGITUDINAL FUNCTIONAL DECLINE AND ATROPHY AFTER PN	16
PD31-06 LONG-TERM OUTCOMES AFTER ISOLATED EPISPADIAS REPAIR	16
MP43-19 NOVEL NANOPARTICLE COATINGS DEMONSTRATE ANTIBACTERIAL AND ANTIBIOFILM PROPERTIES AGAINST MULTIPLE UROPATHOGENS	16

PD49-07 UTILITY OF TESTICULAR SHEAR-WAVE ELASTOGRAPHY IN THE EVALUATION OF PEDIATRIC PATIENTS WITH KLINEFELTER SYNDROME	16
MP76-02 EXPLORING THE EFFECTS OF AMNIOTIC BLADDER THERAPY ON FEMALE SEXUAL DYSFUNCTION IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME PATIENTS	16
PD55-09 THE BALL IS OUT OF OUR COURT: DOES MODERN PRIMARY CARE LITERATURE REFLECT THE AMERICAN UROLOGICAL ASSOCIATION CRYPTORCHIDISM GUIDELINES?	16
MP35-13 PREVALENCE, TRENDS, AND COSTS OF OFFICE-BASED AND AMBULATORY SURGERY CENTER-BASED DIAGNOSTIC CYSTOSCOPY IN THE UNITED STATES	16
PD28-11 O TO ZZZ's: INVESTIGATING THE RELATIONSHIP BETWEEN ORGASM AND SLEEP QUALITY IN WOMEN	16
PD14-10 ENHANCED ANTITUMOR EFFECT OF THE COMBINATION OF BACILLE CALMETTE-GUÉRIN AND AN IMMUNE CHECKPOINT INHIBITOR IN BLADDER CANCER-ON-A-CHIP	15
MP29-20 A PROSPECTIVE, SINGLE CENTER RANDOMISED CONTROLLED TRIAL COMPARING DUSTING AND FRAGMENTATION MODES OF THULIUM FIBER LASER IN RETROGRADE INTRARENAL SURGERY	15
MP36-19 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA	15
PD55-04 IS PERCUTANEOUS NEPHROLITHOTOMY EFFECTIVE AND SAFE IN INFANTS YOUNGER THAN 2 YEARS OLD? COMPARISON OF MINI AND STANDARD PERCUTANEOUS NEPHROLITHOTOMY?	15
MP54-17 FOSTERING DIVERSITY IN UROLOGY: ADDRESSING ETHNIC DISPARITIES IN APPLICANT AND RESIDENT RECRUITMENT	15
MP69-07 UROLOGIC COMPLICATIONS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 (SGLT-2) INHIBITORS DIFFER BETWEEN DIABETIC MEN AND WOMEN	15
MP09-01 TEMPORAL TRENDS OF BPH MEDICATIONS AND PROCEDURES - CONTEMPORARY MEDICARE DATABASE ANALYSIS FROM 2013-2020	15
PD18-09 THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY IN CONTEMPORARY METASTATIC RENAL CELL CARCINOMA: AN OTHER-CAUSE MORTALITY MATCH POPULATION-BASED STUDY	15
MP26-04 HOW MIRABEGRON AFFECTS THE HUMAN URETER: AN IN VITRO STUDY	15
PD33-09 PATHOLOGIC DOWN STAGING WITH NEOADJUVANT CHEMOTHERAPY AS A PREDICTOR OF ONCOLOGICAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A ROBUUST REGISTRY ANALYSIS	15
PD33-10 ROBOT-ASSISTED PARTIAL NEPHRECTOMY WITH HUGO™ RAS SYSTEM: PERIOPERATIVE OUTCOMES AND TRIFECTA ACHIEVEMENT FROM THE LARGEST MULTICENTRIC SERIES	15
PD14-05 THE STROMA-RICH CONSENSUS BLADDER CANCER SUBTYPE CORRELATES WITH IMPROVED PROGNOSIS AFTER NEOADJUVANT IMMUNOTHERAPY AND RADICAL CYSTECTOMY	15
MP30-15 MACHINE LEARNING TO DISTINGUISH BENIGN AND MALIGNANT RENAL LESIONS BASED ON ROUTINE CT IMAGING	14
PD41-11 THE IMPACT OF PROSTATE VOLUMES (≤80 CC VS. > 80 CC) ON PERIOPERATIVE OUTCOMES AND RISK OF RETREATMENT IN PATIENTS UNDERGOING AQUABLATION: A SINGLE-CENTER STUDY	14
PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESP	14
MP75-17 EXAMINING THE RELATIONSHIP BETWEEN DIETARY INFLAMMATORY INDEX AND URINARY FLOW RATE: RESULTS FROM A NATIONWIDE STUDY	14
Precision-guidance vs Systematic Sampling: Optimizing Biopsy Assessment of Secondary Prostate Cancer Suspicious Multiparametric Magnetic Resonance Imaging Lesions	14
PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS OF TREATMENT SEQUENCE	14
V14-05 ARTIFICIAL INTELLIGENCE-BASED INTRAOPERATIVE GUIDANCE: DEMONSTRATION OF REAL-TIME SEGMENTATION AND FEATURE TRACKING IN ROBOTIC SURGERY	14
MP18-02 DOES DEEP LEARNING RECONSTRUCTION IMPROVE URETERAL STONE DETECTION AND SUBJECTIVE IMAGE QUALITY IN THE CT IMAGES OF PATIENTS WITH METAL HARDWARE?	14
MP46-13 ROBOT-ASSISTED RADICAL CYSTECTOMY WITH INTRACORPOREAL PADUA ILEAL NEOBLADDER: LONG-TERM FUNCTIONAL OUTCOMES AND CONTINENCE PREDICTORS ASSESSMENT FROM A HIGH-VOLUME CENTER LARGE CONSECUTIVE SER	14
MP15-10 DISCOVERY OF TBK1 ASSOCIATED ONCOGENIC MECHANISM WHICH MEDIATES THE UPPER-TRACT UROTHELIAL CARCINOMA WITH PREEXISTING END STAGE RENAL DISEASE	14
MP39-14 EVALUATING THE CONTRIBUTION OF THE STANDARDIZED LETTER OF RECOMMENDATION TO A SUCCESSFUL MATCH IN UROLOGY RESIDENCY	14
MP41-11 CIRCULATING MICRORNA PROFILING FOR PREDICTION OF ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS FOLLOWING RADICAL PROSTATECTOMY	14
PD30-07 HIGH-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER DEMONSTRATES HOMOGENEOUS ONCOLOGICAL OUTCOMES REGARDLESS OF EAU 2021 RISK GROUP STRATIFICATION	14
MP70-06 MATCHED ANALYSIS OF URINARY TRACT INFECTIONS AND READMISSIONS AFTER OPEN URETERONEOCYSTOSTOMY: DOES AGE MATTER?	14
V08-03 ENDOSCOPIC RESECTION OF AN ENTEROANASTOMOTIC TUMOR RECURRENCE AFTER RADICAL CYSTECTOMY: A NOVEL APPROACH USING BIPOLAR RESECTION	14
MP49-07 DEFINING HIGH GLEASON SCORE PROSTATE CANCER BY PROSTATE FLUID METABOLIC FINGERPRINT BASED MULTI-MODAL DIAGNOSIS	14
PD05-03 REDUCING EMERGENCY ROOM VISITS THROUGH THE USE OF MULTI-LANGUAGE EDUCATIONAL PAMPHLETS AFTER URETEROSCOPY WITH URETERAL STENT PLACEMENT	14
MP72-09 SELF-SCHEDULING IMPROVES QUALITY OF CARE FOR HOSPITAL DISCHARGE FOLLOW UP OF URINARY RETENTION PATIENTS	13
MP25-06 DEVELOPMENT OF A MULTI-INSTITUTIONAL, SIMULATION-BASED SURGICAL SKILLS BOOTCAMP FOR JUNIOR UROLOGY RESIDENTS	13
MP71-18 PERIPHERAL TIBIAL NERVE STIMULATION DEMONSTRATES LIMITED IMPROVEMENT IN SELF-REPORTED SYMPTOMS FOR PATIENTS WITH OVERACTIVE BLADDER: SINGLE CENTER EXPERIENCE	13
MP05-01 MICRO COMPUTED TOMOGRAPHY ANALYSIS OF MINERAL IN RENAL PAPILLAE SHOWS THAT RANDALL'S PLAQUE FORMATION OCCURS INDEPENDENTLY OF UPSTREAM DUCTAL PLUGGING IN THE MEDULLA	13
MP74-18 DETRUSOR VOIDING CONTRACTION VELOCITY IS RELEVANT TO PATIENTS WITHOUT BLADDER OUTFLOW OBSTRUCTION	13
PD25-05 CHRONIC EXPOSURE OF PHYSIOLOGICAL CONCENTRATION OF ARSENIC INDUCED BLADDER MALIGNANCY IN PRECLINICAL MODELS	13
MP47-03 TRENDS IN SBRT FOR INOPERABLE RENAL CELL CARCINOMA	13
PD10-10 IMPROVING PREDICTION OF LOCAL STAGE BY PSMA-PET. DEVELOPMENT OF A NOVEL INTEGRATED TOOL FOR EXTRACAPSULAR EXTENSION AND SEMINAL VESICLE INVASION COMBINING CLINICAL AND IMAGING FEATURES IN LOCA	13
MP35-11 TRENDS AND INCIDENCE OF REPORTED EVENTS ASSOCIATED WITH URETERAL STENTS: AN ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION'S MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE DATABASE	13
MP15-09 TADALAFIL VERSUS COMBINED TAMSOLUSIN AND CIPROFLOXACIN FOR TREATMENT OF CHRONIC PELVIC PAIN SYNDROME: A RANDOMIZED CONTROLLED TRIAL	13
MP61-11 RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY AFTER PREVIOUS TRANS-URETHRAL RESECTION OF THE PROSTATE: ASSESSMENT OF FUNCTIONAL AND ONCOLOGICAL OUTCOMES	13
MP79-10 PHARMACOVIGILANCE ANALYSIS OF MELANOMA ADVERSE EVENTS IN MEN TREATED WITH SILDENAFIL FOR ERECTILE DYSFUNCTION	13
MP44-08 RELATIONSHIP BETWEEN COVID 19 VACCINATION AND PSA LEVEL	13
PD08-11 ACTIVE SURVEILLANCE VERSUS PRIMARY INTERVENTION FOR CLINICAL T1a KIDNEY TUMORS: TWELVE-YEAR EXPERIENCE OF THE DISSRM PROSPECTIVE COMPARATIVE STUDY	13
MP72-17 SURGEON’S PERSONAL OPIOID BEHAVIORS IMPACT POST-OPERATIVE PRESCRIBING FOR OUTPATIENT PROCEDURES	13
PD45-03 FACTORS AFFECTING HOLMIUM LASER INEFFICIENCY: COMPARISON OF LARYNGEAL MASK AIRWAY AND ENDOTRACHEAL TUBE USE DURING FLEXIBLE URETEROSCOPY FOR RENAL STONES	13
Editorial Comment	12
First Series Using Ultrasonic Propulsion and Burst Wave Lithotripsy to Treat Ureteral Stones	12
FINAL RESULTS: BOND-003 COHORT C- PHASE 3, SINGLE-ARM STUDY OF INTRAVESICAL CRETOSTIMOGENE GRENADENOREPVEC FOR HIGH-RISK BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU	12
Remission and Transition of Female Urinary Incontinence and Its Subtypes and the Impact of Body Mass Index on This Progression: A Nationwide Population-Based 4-Year Longitudinal Study in China	12
IP23-07 ANATOMY OF A COMPLICATION: CLINICO-RADIOLOGIC FEATURES OF BLEEDINGS AFTER ROBOTIC-ASSISTED RADICAL PROSTATECTOMY. THE ROLE OF THE OBTURATOR ARTERY VARIANTS	12
HF02-14 HERNIAS, HEALING, HAGIOGRAPHY: AN ANALYSIS OF ST. ARTEMIOS AND BYZANTINE INCUBATION RITUALS	12
LBA02-12 IS LEARNING CURVE IMPORTANT WHILE PERFORMING PSMA-PET? ANALYSIS OF DETECTION RATE ACCORDING TO GLEASON SCORE AND PSA LEVEL IN TWO TIMEFRAMES AT A BRAZILIAN HIGH-VOLUME CENTER	12
MP06-20 SIGNIFICANT REDUCTION OF PERIOPERATIVE SERIOUS REPORTABLE EVENTS THROUGH A NOVEL SURGICAL SAFETY CHECKLIST AND TIME-OUT PROCEDURE	12
Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level	12
Robotic Urologic Oncologic Surgery: Ever-Widening Horizons	12
Editorial Comment	12
Hooman Djaladat, MD, MS	12
Health-related Quality of Life After Robotic-assisted vs Open Radical Cystectomy: Analysis of a Randomized Trial	12
Pro: Does COVID Affect Male Reproductive Health?	12
MP75-10 SURVIVAL OUTCOMES BY RACE FOLLOWING MINIMALLY INVASIVE SURGICAL TREATMENT FOR UPPER TRACT UROTHELIAL CARCINOMA: AN ANALYSIS OF THE ROBUUST REGISTRY	12
MP58-04 PROPOSAL AND INTERNAL VALIDATION OF A NOMOGRAM FOR THE PREDICTION OF LOCAL RECURRENCE FREE-SURVIVAL AFTER PERCUTANEOUS ABLATION FOR CT1 RENAL MASSES	12
MP20-07 NPTX1 IS A NOVEL SERUM BIOMARKER INDUCED BY ARPI TREATED PROSTATE CANCER AND ENRICHED IN LINEAGE PLASTICITY WITH BRN2 HIGH	12
MP11-16 PROSTATE-SPECIFIC ANTIGEN ANALYSES IN PROPEL: ABIRATERONE AND OLAPARIB VERSUS ABIRATERONE AND PLACEBO AS FIRST-LINE THERAPY FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER	12
Male Infertility	12
MP09-16 INFORMING AN APPROACH TO THE SUBCAPSULAR RENAL HEMATOMA (SRH): A TEN-YEAR REVIEW OF THE NATURAL HISTORY AND PROGRESSION OF SRH	12
Genital Hypoplasia in Gender-affirming Vaginoplasty: Prior Orchiectomy, Penile Length, and Other Factors to Guide Surgical Planning	12
PD36-05 DEEP LEARNING PREDICTIVE MODEL FOR PROSTATE CANCER RECURRENCE USING CLINICAL AND HISTOLOGICAL DATA FROM THE TCGA DATABASE	12
PD26-04 A RANDOMIZED STUDY TO COMPARE OUTCOMES OF INTRAVESICAL CHEMOHYPERTHERMIA WITH MITOMYCIN C VS INTRAVESICAL BCG FOR INTERMEDIATE AND HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)	12
Food Sensitivities in a Diverse Nationwide Cohort of Veterans With Interstitial Cystitis/Bladder Pain Syndrome	12
PD24-07 FIRST ANALYSIS OF THE SAFETY AND EFFICACY OF UGN-101 IN THE TREATMENT OF URETERAL TUMORS	12
MP53-05 RISK OF ACUTE KIDNEY INJURY AFTER LOWER URINARY TRACT RECONSTRUCTION WITH EARLY NSAID THERAPY: A PROPENSITY MATCHED RETROSPECTIVE ANALYSIS	12
MP03-19 ROLE OF MICROFIBRILLAR-ASSOCIATED PROTEIN 4 IN PARTIAL BLADDER OUTFLOW OBSTRUCTION-RELATED BLADDER FIBROSIS	12
Comparative Outcomes of Salvage Retzius-Sparing versus Standard Robotic Prostatectomy: An International, Multi-Surgeon Series	12
Editorial Comment	11
Imaging	11
Size Matters, at Least Sometimes…	11
Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Pelvic Prolapse (PD44)	11
Prostate Cancer: Localized: Active Surveillance (MP38)	11
Editorial Comment	11
Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice	11
Editorial Comment	11
Socioeconomic Factors, Urological Epidemiology, and Practice Patterns	11
Infertility: Epidemiology & Evaluation II (PD18)	11
Male and Female Sexual Function and Dysfunction; Andrology	11
Surgical Technology & Simulation: Instrumentation & Technology (IP11)	11
Editorial Comment	11
This Month in Adult Urology	11
Editorial Comment	11
Bladder Cancer: Invasive VI (MP77)	11
Health Services Research: Practice Patterns, Quality of Life and Shared Decision Making II (MP09)	11